Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOST: Argatroban or Eptifibatide in Acute Ischemic Stroke
NCT03735979Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of argatroban, eptifibatide in ischemic stroke, sponsored by Washington University School of Medicine. Started Oct 2019; status: completed.
02
Drugs
argatrobaneptifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03735979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735979.